CompletedNCT05701345
Virtual reality-based medical device study for depression
About this title
Read the official source — NCT05701345Device studyAges 19–64South Korea
Understand this study
Who was this study for?
Listed age limits: 19 years to 64 years.
- Listed locations
- Ilsan and 4 more locationsSee all locations and recruitment
Study information
Study start dateStarted: March 9, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 162
- Sponsor
- Omni C&S
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device, Other
- Locations
- South Korea
- Age range
- From 19 Years to 64 Years
- Official registry ID
- NCT05701345
- Official title
Show the full official title
Prospective, Multicenter, Assessor-blind, Randomized, Comparative, Pivotal Study to Evaluate the Efficacy and Safety of Wearable Visual Device (HMD)-VR-based Software Medical Device(OMNIFIT DTx-MDD) for Patients with Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ilsan · Jeju City · Seoul
1 more locations
- Suwon
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Omni C&S.
Who was this study for?
Listed age limits: 19 years to 64 years.
